LARS promotes hepatocellular carcinoma progression via the PI3K/AKT/mTOR pathway and interaction with RPS5, and serves as a prognostic biomarker.

Mol Med · 2026 · PMC13277034 · PMID 42062902

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

highly significantno p-value reported

In LIHC, comparison of normal tissues with N0 stage showed highly significant differences, while normal versus N1 stage did not reach statistical significance (Fig. 8 h).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.